Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Molecular Immunology|February 5, 2008
The crystal structure of the pathogenic collagen type II-specific mouse monoclonal antibody CIIC1 Fab: structure to function analysisHüseyin Uysal, Bettina Sehnert, Kutty S Nandakumar, et al.
BMC Medical Genetics|May 14, 2020
Genetic variants in FBLIM1 gene do not contribute to SAPHO syndrome and chronic recurrent multifocal osteomyelitis in typical patient groupsGunter Assmann, Michaela Köhm, Volker Schuster, et al.
Clinical Rheumatology|June 1, 2020
Correction to: Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort studyFrank Behrens, Hans-Peter Tony, Michaela Koehm, et al.
The Journal of Investigative Dermatology|January 27, 2007
Loss-of-function variants of the filaggrin gene are not major susceptibility factors for psoriasis vulgaris or psoriatic arthritis in German patientsUlrike Hüffmeier, Heiko Traupe, Vinzenz Oji, et al.
Arthritis Research & Therapy|September 28, 2007
A case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunityLina M Olsson, Anna-Karin Lindqvist, Henrik Källberg, et al.
Arthritis Care & Research|March 19, 2016
Association of Improvement in Pain With Therapeutic Response as Determined by Individual Improvement Criteria in Patients With Rheumatoid ArthritisEva C Scharbatke, Frank Behrens, Marc Schmalzing, et al.
Arthritis and Rheumatism|December 31, 2005
Association between protein tyrosine phosphatase 22 variant R620W in conjunction with the HLA-DRB1 shared epitope and humoral autoimmunity to an immunodominant epitope of cartilage-specific type II collagen in early rheumatoid arthritisHarald Burkhardt, Ulrike Hüffmeier, Bernd Spriewald, et al.
Clinical Rheumatology|March 25, 2020
Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort studyFrank Behrens, Hans-Peter Tony, Michaela Koehm, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 29, 2014
Identification of new citrulline-specific autoantibodies, which bind to human arthritic cartilage, by mass spectrometric analysis of citrullinated type II collagenSabrina Haag, Nadine Schneider, Daniel E Mason, et al.
Annals of the Rheumatic Diseases|May 15, 2009
Deletion of LCE3C and LCE3B genes at PSORS4 does not contribute to susceptibility to psoriatic arthritis in German patientsUlrike Hüffmeier, Xavier Estivill, Eva Riveira-Munoz, et al.
Pageof 10